Concepedia

Angelique A. C. Lemckert

AA

Statistics

Publications

26

Citations

3.6K

H-Index

21

Active since

2001

Affiliations

Johnson & Johnson (Netherlands)(Current)

Harvard University

Beth Israel Deaconess Medical Center

Leiden University Medical Center

Batavia Biosciences (Netherlands)

Angelique A. C. Lemckert is an author at Johnson & Johnson (Netherlands) specializing in adenovirus vectors, adenoviral vectors, and life sciences.

Publications per year

2001–2021

26

Publications

26

Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

Peter Abbink, Angelique A. C. Lemckert, Bonnie A. Ewald et al. · Journal of Virology · 2007 · 516 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

D.M. Roberts, Anjali Nanda, Menzo Havenga et al. · Nature · 2006 · 489 citations

Life Sciences, Immunology, Molecular Biology +14

Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

Ronald Vogels, David Zuijdgeest, Richard van Rijnsoever et al. · Journal of Virology · 2003 · 471 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein

Shawn M. Sumida, Diana M. Truitt, Angelique A. C. Lemckert et al. · The Journal of Immunology · 2005 · 363 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of Disease

Menzo Havenga, Angelique A. C. Lemckert, Olga Ophorst et al. · Journal of Virology · 2002 · 192 citations · Full text

Life Sciences, Molecular Biology, Gene Therapy +15

1–5 of 26